Shares of DocuSign are a great value investment in a very expensive market, especially as the stock now sits at a ~15x ex-cash P/E against next year's earnings. Growth has stabilized in the high single digits, while a new product release contains potential for future upsells. Over the long haul, DocuSign benefits from a $50 billion TAM, high gross margins, and significant cash reserves, positioning it well for long-term growth and scalability.
Does DocuSign (DOCU) have what it takes to be a top stock pick for momentum investors? Let's find out.
Artificial intelligence is spreading, and it's transforming some businesses you might not have expected.
DocuSign (DOCU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
DocuSign (DOCU) stock price has underperformed the market in the past few years. It was trading at $60 on Tuesday, where it has been stuck for a while.
The recent acquisition of Lexion fortifies DOCU's position in Intelligent Agreement Management (IAM) by adding more AI-assisted capabilities to its IAM platform.
Investment in growth stocks should be fruitful on rate cut hope. Five growth stocks to be purchased for September are DOCU, SPOT, UI, UHS and VRT.
DocuSign reported solid results that easily surpassed its forecasts. However, modest billings growth continues to weigh on the stock.
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
DOCU aims to acquire eSignature customers, expand the product's usage, popularize other Agreement Cloud products and globalize.
Demand for Docusign's digital document software sent its stock soaring during the worst of the pandemic. The company's revenue growth is now slowing, and its stock is trading near the cheapest level since it came public in 2018.